Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

18.09
Delayed Data
As of Jul 31
 -0.09 / -0.50%
Today’s Change
15.56
Today|||52-Week Range
20.60
+9.90%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 19.00, with a high estimate of 22.00 and a low estimate of 15.00. The median estimate represents a +5.03% increase from the last price of 18.09.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.21
Sales
$48.6M
Reporting Date
Nov 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.90%
 
 
 
 
 
 
Growthannually 3.44%
 
 
 
 
 
 

Sales

Growthquarterly 0.83%
 
 
 
 
 
 
Growthannually 4.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.